Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here